Metastatic Renal Pelvis Urothelial Carcinoma

11 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Metastatic Renal Pelvis Urothelial Carcinoma

Record	Firm	Date
Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy (NCT04963153)	National Cancer Institute (NCI)	2022-07-07
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study (NCT05092958)	National Cancer Institute (NCI)	2022-06-03
Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594)	Alliance for Clinical Trials in Oncology	2022-05-27
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma (NCT04940299)	M.D. Anderson Cancer Center	2021-09-23
Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma (NCT04848519)	Emory University	2021-05-20
Adoptive Cell Therapy With (LN-145) in Combination With Pembrolizumab in Treating Patients With Unresectable or Metastatic Transitional Cell Cancer Who Have Failed Cisplatin-Based Chemotherapy (NCT03935347)	Roswell Park Cancer Institute	2019-06-20
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma (NCT03513952)	National Cancer Institute (NCI)	2019-06-05
Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer (NCT03237780)	National Cancer Institute (NCI)	2018-07-20
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer (NCT00942331)	National Cancer Institute (NCI)	2009-07-15

Track Metastatic Renal Pelvis Urothelial Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.